Search Within

Narek Shaverdian

  1. "Interventional Radiology Service"
Formats
  1. Journal Article (2)
  2. Meeting Abstract (2)
Groups
  1. GME, Radiation Oncology (4)
  2. Graduate Medical Education (4)
  3. Interventional Radiology Service (4)
  4. Radiation Oncology, Department of (4)
  5. Radiology, Department of (4)
  6. Biostatistics Service (3)

More Groups

People
  1. Daphna Gelblum (4)
  2. Zhigang Zhang (3)
  3. Abraham Wu (2)
  4. Alexander Drilon (2)
  5. Amy Xu (2)
  6. Andreas Rimner (2)

More People

Years
  1. 2024 (1)
  2. 2022 (2)
  3. 2021 (1)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (2)
  2. JCO Precision Oncology (1)
  3. Neurosurgery (1)
Publishers
  1. Elsevier Inc. (2)
  2. American Society of Clinical Oncology (1)
  3. Wolters Kluwer (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • 40 gray in 5 fractions for salvage reirradiation of spine lesions previously treated with stereotactic body radiotherapy
    Journal Article

    Moore, A.; Zhang, Z.; Fei, T.; Zhang, L.; Accomando, L.; Schmitt, A. M.; Higginson, D. S.; Mueller, B. A.; Zinovoy, M.; Gelblum, D. Y.; more...
    Neurosurgery (2024)

    Fulltext@MSK | Save
  • Outcomes with local therapy and tyrosine kinase inhibition in patients with ALK/ROS1/RET-rearranged lung cancers
    Journal Article

    Hubbeling, H.; Choudhury, N.; Flynn, J.; Zhang, Z. G.; Falcon, C.; Rusch, V. W.; Park, B. J.; Ziv, E.; Shaverdian, N.; Gelblum, D. Y.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • 40 Gray in 5 fractions for salvage re-irradiation of spine lesions previously treated with stereotactic body radiotherapy
    Meeting Abstract

    Moore, A.; Zhang, Z.; Schmitt, A.; Higginson, D. S.; Mueller, B. A.; Zinovoy, M.; Gelblum, D.; Yerramilli, D.; Xu, A. J.; Brennan, V. S.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Outcomes with local therapy and tyrosine kinase inhibition in patients with ALK/ROS1/RET-rearranged lung cancers
    Meeting Abstract

    Hubbeling, H. G.; Choudhury, N.; Falcon, C.; Rusch, V. W.; Park, B.; Ziv, E.; Shaverdian, N.; Gelblum, D.; Shepherd, A. F.; Simone, C. B. 2nd; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save